626 related articles for article (PubMed ID: 6238627)
1. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
Hidaka H; Inagaki M; Kawamoto S; Sasaki Y
Biochemistry; 1984 Oct; 23(21):5036-41. PubMed ID: 6238627
[TBL] [Abstract][Full Text] [Related]
2. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
[TBL] [Abstract][Full Text] [Related]
3. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
Hagiwara M; Inagaki M; Watanabe M; Ito M; Onoda K; Tanaka T; Hidaka H
Mol Pharmacol; 1987 Jul; 32(1):7-12. PubMed ID: 2955213
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives.
Lu ZX; Quazi NH; Deady LW; Polya GM
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):373-84. PubMed ID: 8839983
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
Chijiwa T; Mishima A; Hagiwara M; Sano M; Hayashi K; Inoue T; Naito K; Toshioka T; Hidaka H
J Biol Chem; 1990 Mar; 265(9):5267-72. PubMed ID: 2156866
[TBL] [Abstract][Full Text] [Related]
6. KT5926, a potent and selective inhibitor of myosin light chain kinase.
Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
[TBL] [Abstract][Full Text] [Related]
7. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
Robinson PJ; Cheng HC; Black CK; Schmidt CJ; Kariya T; Jones WD; Dage RC
J Pharmacol Exp Ther; 1990 Dec; 255(3):1392-8. PubMed ID: 2175806
[TBL] [Abstract][Full Text] [Related]
8. N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide, a novel activator of protein kinase C.
Ito M; Tanaka T; Inagaki M; Nakanishi K; Hidaka H
Biochemistry; 1986 Jul; 25(15):4179-84. PubMed ID: 3756133
[TBL] [Abstract][Full Text] [Related]
9. Design of potent protein kinase inhibitors using the bisubstrate approach.
Ricouart A; Gesquiere JC; Tartar A; Sergheraert C
J Med Chem; 1991 Jan; 34(1):73-8. PubMed ID: 1992155
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of myosin light chain kinase, cAMP-dependent protein kinase, protein kinase C and of plant Ca(2+)-dependent protein kinase by anthraquinones.
Jinsart W; Ternai B; Polya GM
Biol Chem Hoppe Seyler; 1992 Sep; 373(9):903-10. PubMed ID: 1466788
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by melittin of phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.
Katoh N; Raynor RL; Wise BC; Schatzman RC; Turner RS; Helfman DM; Fain JN; Kuo JF
Biochem J; 1982 Jan; 202(1):217-24. PubMed ID: 6896276
[TBL] [Abstract][Full Text] [Related]
12. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
13. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
Nakajima T; Katoh A
Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
[TBL] [Abstract][Full Text] [Related]
14. The fungal teratogen secalonic acid D is an inhibitor of protein kinase C and of cyclic AMP-dependent protein kinase.
Wang BH; Polya GM
Planta Med; 1996 Apr; 62(2):111-4. PubMed ID: 8657739
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
J Biol Chem; 1996 Oct; 271(42):26157-64. PubMed ID: 8824261
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eukaryote protein kinases and of a cyclic nucleotide-binding phosphatase by prenylated xanthones.
Lu ZX; Hasmeda M; Mahabusarakam W; Ternai B; Ternai PC; Polya GM
Chem Biol Interact; 1998 Jul; 114(1-2):121-40. PubMed ID: 9744560
[TBL] [Abstract][Full Text] [Related]
17. Regulation of contractile activity in vascular smooth muscle by protein kinases.
Silver PJ
Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of cyclic AMP-dependent protein kinase, myosin light chain kinase and protein kinase C by azaacridine and acridine derivatives.
Chen Q; Deady LW; Polya GM
Biol Chem Hoppe Seyler; 1994 Apr; 375(4):223-35. PubMed ID: 8060530
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormones inhibit the Ca2+ calmodulin-induced activation of myosin light chain kinase.
Hagiwara M; Mamiya S; Ochiai M; Hidaka H
Biochem Biophys Res Commun; 1988 Apr; 152(1):270-6. PubMed ID: 3358764
[TBL] [Abstract][Full Text] [Related]
20. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.
Kase H; Iwahashi K; Nakanishi S; Matsuda Y; Yamada K; Takahashi M; Murakata C; Sato A; Kaneko M
Biochem Biophys Res Commun; 1987 Jan; 142(2):436-40. PubMed ID: 3028414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
